PAYLESS COMPOUNDERS, LLC recalls

1 recalls.

• Semaglutide-Glycine-Cyanocobalamin Injectable recall (PAYLESS COMPOUNDERS, LLC)
  DrugClass IIReported April 22, 2026 · Lack of Assurance of Sterility